NYSE:BLCOMedical Equipment
Bausch + Lomb (BLCO) Starts 2026 With Ongoing Losses That Test Bullish Margin Narratives
Bausch + Lomb (NYSE:BLCO) has just opened 2026 earnings season with Q1 results that follow a 2025 finish where Q4 revenue was US$1.4b and the company recorded a basic EPS loss of US$0.16 on net income of US$58 million in the red. Over recent quarters, revenue has run from US$1.14b in Q1 2025 to US$1.4b in Q4 2025, while basic EPS has ranged from a loss of US$0.60 to a loss of US$0.08. This has set the stage for investors to focus squarely on how efficiently that top line is converting into...